Skip to content
GenoLensGenoLens

NAXD

Chr 13q34

NAD(P)HX dehydratase

Aliases:
LP3298, FLJ10769
MANE:
ENST00000680254.1

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Mitochondrial disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Paediatric or syndromic cardiomyopathy

    BIALLELIC, autosomal or pseudoautosomal
  • White matter disorders and cerebral calcification - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Epidermolysis bullosa and congenital skin fragility

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • NAD(P)HX dehydratase deficiency

    0.75
  • encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy

    0.55
  • inborn mitochondrial metabolism disorder

    0.37
  • mitochondrial disease

    0.37
  • tympanic membrane perforation

    0.28
  • tympanic membrane disorder

    0.28
  • central nervous system cancer

    0.26
  • protozoa infectious disease

    0.26
  • cerebral atherosclerosis

    0.25
  • peritonitis

    0.25

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

ATP-dependent (S)-NAD(P)H-hydrate dehydratase

Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ATP, which is converted to ADP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S- and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.